These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38754983)

  • 1. Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosis.
    Huang M; Tabib T; Khanna D; Assassi S; Domsic R; Lafyatis R
    Ann Rheum Dis; 2024 Sep; 83(10):1335-1344. PubMed ID: 38754983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Changes Implicate Angiogenesis and Arterial Remodeling in Systemic Sclerosis-Associated and Idiopathic Pulmonary Hypertension.
    Zhou Y; Tabib T; Huang M; Yuan K; Kim Y; Morse C; Sembrat J; Valenzi E; Lafyatis R
    Arterioscler Thromb Vasc Biol; 2024 Aug; 44(8):e210-e225. PubMed ID: 38841857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Reduction in Chromatin Accessibility and Unique Transcription Factor Footprints in Endothelial Cells and Fibroblasts in Scleroderma Skin.
    Tsou PS; Palisoc PJ; Ali M; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2021 Aug; 73(8):1501-1513. PubMed ID: 33586346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.
    Tsou PS; Wren JD; Amin MA; Schiopu E; Fox DA; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2016 Dec; 68(12):2975-2985. PubMed ID: 27482699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin.
    Apostolidis SA; Stifano G; Tabib T; Rice LM; Morse CM; Kahaleh B; Lafyatis R
    Front Immunol; 2018; 9():2191. PubMed ID: 30327649
    [No Abstract]   [Full Text] [Related]  

  • 6. Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.
    Tsou PS; Rabquer BJ; Ohara RA; Stinson WA; Campbell PL; Amin MA; Balogh B; Zakhem G; Renauer PA; Lozier A; Arasu E; Haines GK; Kahaleh B; Schiopu E; Khanna D; Koch AE
    Rheumatology (Oxford); 2016 Apr; 55(4):745-54. PubMed ID: 26705326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.
    Mendoza FA; Piera-Velazquez S; Farber JL; Feghali-Bostwick C; Jiménez SA
    Arthritis Rheumatol; 2016 Jan; 68(1):210-7. PubMed ID: 26360820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
    Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.
    Mostmans Y; Cutolo M; Giddelo C; Decuman S; Melsens K; Declercq H; Vandecasteele E; De Keyser F; Distler O; Gutermuth J; Smith V
    Autoimmun Rev; 2017 Aug; 16(8):774-786. PubMed ID: 28572048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis.
    Manetti M; Ibba-Manneschi L; Liakouli V; Guiducci S; Milia AF; Benelli G; Marrelli A; Conforti ML; Romano E; Giacomelli R; Matucci-Cerinic M; Cipriani P
    Ann Rheum Dis; 2010 Mar; 69(3):598-605. PubMed ID: 19778913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis-Associated Interstitial Lung Disease.
    Papazoglou A; Huang M; Bulik M; Lafyatis A; Tabib T; Morse C; Sembrat J; Rojas M; Valenzi E; Lafyatis R
    Arthritis Rheumatol; 2022 Dec; 74(12):2003-2014. PubMed ID: 35849803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Cysteine-Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in Scleroderma.
    Tsou PS; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2019 Aug; 71(8):1350-1359. PubMed ID: 30884213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
    Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
    Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
    J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis.
    Rabquer BJ; Tsou PS; Hou Y; Thirunavukkarasu E; Haines GK; Impens AJ; Phillips K; Kahaleh B; Seibold JR; Koch AE
    Arthritis Res Ther; 2011 Feb; 13(1):R18. PubMed ID: 21303517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
    Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis.
    Andreucci E; Margheri F; Peppicelli S; Bianchini F; Ruzzolini J; Laurenzana A; Fibbi G; Bruni C; Bellando-Randone S; Guiducci S; Romano E; Manetti M; Matucci-Cerinic M; Calorini L
    Rheumatology (Oxford); 2021 Oct; 60(10):4508-4519. PubMed ID: 33471123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis.
    Yin H; Distler O; Shen L; Xu X; Yuan Y; Li R; Liu B; Li Q; Huang Q; Xie F; Zhang Z; Liang R; Dai X; Chen X; Li B; Yan Q; Lu L
    Arthritis Rheumatol; 2024 Jan; 76(1):78-91. PubMed ID: 37488975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of junctional adhesion molecules in different stages of systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Rosa I; Ceccarelli C; Mello T; Milia AF; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Rheum; 2013 Jan; 65(1):247-57. PubMed ID: 23001478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.